Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

With a lack of venture capital funding, biotechs are increasingly slashing budget and adapting more virtual principles. Going virtual has been one trend that is gaining popularity in the biotech ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Biotech is a high-risk ... What may set this company apart from a host of similar penny stock biotechs, however, is its investigational allogeneic cell therapy being studied in type 1 diabetes.

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Discover how small biotechs are innovating in the weight loss therapy market with new treatments targeting unique mechanisms ...

Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer ... news for patients and should motivate U.S. biotechs to do the same," they added.